Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Comcast Shines Brighter Than Ever

By Alyssa Oursler, InvestorPlace Contributor
Media stocks in general are probably ready for a breather after the year they've had -- but CMCSA still has room to move up more.

Hotel Stocks Retreat on Weakness Overseas

By Dan Burrows, InvestorPlace Feature Writer
A big hot run-up looks to be over for the big names in this group, thanks to slippage in Europe and some Asian markets.

BlackBerry’s Co-Founder Dumps His Stake

By Tom Taulli, InvestorPlace Contributor
Jim Balsillie sells his shares, but it may not mean much considering that he no longer plays a role at the company.

Berkshire Hathaway Partners for $23B Heinz Purchase

By Christopher Freeburn, InvestorPlace Writer
Heinz has agreed to be acquired by a partnership between Warren Buffett's Berkshire Hathaway and Brazil's 3G Capital in a deal worth $23 billion.

Steel Industry to Suffer as China’s Iron Ore Appetite Slows

By Christopher Freeburn, InvestorPlace Writer
Hedge fund manager Andrew Feldstein says falling demand for steel from China and lower iron ore prices will batter the steel industry.

Winners After Novo Nordisk’s Insulin Rejection

By James Brumley, InvestorPlace Feature Writer
Eli Lilly and Sanofi look like the biggest players that are best suited to benefit from Novo Nordisk's diabetes-drug setback, but a smaller player could emerge, too.

Poor U.S. Retail Sales Send Gold Lower

By Christopher Freeburn, InvestorPlace Writer
Weak U.S. retail sales for January sent gold down slightly in Wednesday trading as investors looked forward to the G-20 meeting in Moscow this week.

GE, Comcast Go Dealing — Wednesday’s IP Market Recap

By Marc Bastow, InvestorPlace Assistant Editor
CMCSA's buyout of remaining NBCUniversal stake sends it and General Electric higher, though the broader indices saw more mixed, muted results.

The $10 Billion Boring Growth Stock

By Lawrence Meyers, InvestorPlace Contributor
C.H. Robinson is a transport and logistics service that's mega-profitable. One reason: It doesn't actually buy any of its own transportation equipment.

Don’t Count on China to Buy America’s Coal

By Aaron Levitt, InvestorPlace Contributor
Uh-oh, turns out the Asian giant is already working on other plans that promise to reduce its demand for coal from U.S. producers.

Who Should Bid at the Hostess Auction?

By James Brumley, InvestorPlace Feature Writer
Walmart and PepsiCo are among intriguing possibilities as potential bidders for Hostess brands like Twinkies and Wonder Bread.

Good Day For Luxury, Lipstick — Tuesday’s IP Market Recap

By Marc Bastow, InvestorPlace Assistant Editor
Luxury names Michael Kors and Fossil headed higher on earnings news Tuesday, as did beauty products mainstay Avon.

Gold Mostly Flat After G7 Statement

By Christopher Freeburn, InvestorPlace Writer
Gold was mostly flat in Tuesday trading after a G7 statement against currency devaluation sent the U.S. dollar lower and North Korea conducted a nuclear test.

Gold Drops to 5-Week Low on G-7 Rumblings

By Christopher Freeburn, InvestorPlace Writer
Gold and silver slid lower Monday amid news of a possible G-7 statement against currency devaluations; miners turned tail as well.

Little News, Little Wiggle — Monday’s IP Market Recap

By Marc Bastow, InvestorPlace Assistant Editor
A slow Monday featured a lack of economic or earnings news and led investors to mostly sit on the sidelines for the day.

Ford Makes Big Push for Dealership Renovations

By Christopher Freeburn, InvestorPlace Writer
Ford announced on Sunday that it will match the costs of remodeling for all of its dealerships up to $750,000.

Biotech Movers: A Doubler for Opexa

By Kyle Woodley, Senior Investing Editor, Kiplinger
A good week for little guys Opexa Therapeutics and Hyperion Therapeutics and giant Biogen. But Hemispherx BioPharma and BioCryst Pharmaceuticals had downers.

AFLAC Is Still a Solid Long Term Buy

By Ed Elfenbein, Editor of Crossing Wall Street
AFLAC remains a solid dividend player despite some possible forward earnings weakness due to currency exchange issues in its Japanese operations

Gold Posts Weekly Loss on Lower U.S. Trade Deficit

By Christopher Freeburn, InvestorPlace Writer
A sharp drop in the U.S. trade deficit for December sent gold lower in Friday trading, pushing the metal to a weekly loss.
Load More Articles